Leidos affiliate plans sale of 10,000 shares

Leidos Holdings, Inc. received a notice of proposed sale of common stock under Form 144.

Rhea-AI Filing Summary

Leidos Holdings, Inc. received a notice of proposed sale of common stock under Form 144. A selling stockholder plans to sell 10,000 shares of common stock through Robert W. Baird & Co. on or after August 11, 2026, with an aggregate market value of $1,390,800.00. The shares were originally acquired as restricted stock unit compensation in multiple grants dated August 27, 2025, March 4, 2026, and May 1, 2026.

Key Figures

Shares to be sold: 10,000 shares Aggregate market value: $1,390,800.00 Earliest sale date: 08/11/2026 +1 more

4 metrics

Shares to be sold 10,000 shares Proposed sale of Leidos Holdings, Inc. common stock under Form 144

Aggregate market value $1,390,800.00 Total market value of 10,000 shares proposed for sale

Earliest sale date 08/11/2026 Date from which shares may be sold under the Form 144 notice

RSU grant shares 2,123; 1,769; 2,296; 873; 2,939 shares Individual RSU-based compensation grants backing the 10,000 shares

Key Terms

Form 144, restricted stock units, aggregate market value

3 terms

Form 144 regulatory

"Leidos Holdings, Inc. received a notice of proposed sale of common stock under Form 144."

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

restricted stock units financial

"The shares were originally acquired as restricted stock unit compensation in multiple grants."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

aggregate market value financial

"An aggregate market value of $1,390,800.00 applies to the 10,000 shares."

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Leidos Holdings (LDOS) shares are planned to be sold under this Form 144?

The Form 144 covers a proposed sale of 10,000 shares of Leidos Holdings, Inc. common stock. These shares are to be sold through Robert W. Baird & Co. as the broker.

What is the aggregate market value of the LDOS shares covered by this Form 144?

The planned sale has an aggregate market value of $1,390,800.00. This value reflects the total for the 10,000 shares of Leidos Holdings, Inc. common stock listed in the notice.

When may the selling stockholder of LDOS begin selling the shares?

The proposed sale is dated August 11, 2026, which is the earliest date the shares may be sold. Actual sales can occur on or after that date, subject to applicable rules.

How were the LDOS shares in this Form 144 originally acquired?

All covered shares were acquired as compensation in the form of restricted stock units. The grants occurred on multiple dates, including 08/27/2025, 03/04/2026, and 05/01/2026.

What specific restricted stock unit grants back the LDOS shares in this sale?

The notice lists RSU-based acquisitions of 2,123, 1,769, 2,296, 873, and 2,939 shares. Together these compensation grants total 10,000 shares of Leidos Holdings, Inc. common stock.

Which broker is handling the proposed LDOS stock sale in this Form 144?

The selling stockholder has designated Robert W. Baird & Co., located at 1600 West End Avenue, Suite 1100, Nashville, TN 37203, as the broker for the 10,000-share sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/11/2026 - 03:39 PM Accepted by SEC EDGAR 08/11/2026 - 03:38 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001216858
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Leidos Holdings, Inc.
SEC File Number	001-33072
Address of Issuer	1750 Presidents Street Reston VIRGINIA 20190
Phone	571-526-6000
Name of Person for Whose Account the Securities are To Be Sold	Noel B. Geer
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Robert W. Baird & Co. 1600 West End Avenue Suite 1100 Nashville TN 37203	10000	1390800.00	125492209	08/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/04/2026	Acquired as compensation - restricted stock units	Leidos Holdings, Inc.			2123	03/04/2026	Compensation
Common Stock	03/04/2026	Acquired as compensation - restricted stock units	Leidos Holdings, Inc.			1769	03/04/2026	Compensation
Common Stock	03/04/2026	Acquired as compensation - restricted stock units	Leidos Holdings, Inc.			2296	03/04/2026	Compensation
Common Stock	05/01/2026	Acquired as compensation - restricted stock units	Leidos Holdings, Inc.			873	05/01/2026	Compensation
Common Stock	08/27/2025	Acquired as compensation - restricted stock units	Leidos Holdings, Inc.			2939	08/27/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Trades executed under the Noel B. Geer Living Trust
Date of Notice	08/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Noel B. Geer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)